Inovio Pharmaceuticals
INO
#9183
Rank
HK$0.87 B
Marketcap
HK$12.73
Share price
1.24%
Change (1 day)
-21.83%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.50. In 2024 the company made an earnings per share (EPS) of -HK$30.86 an increase over its 2023 EPS that were of -HK$47.58.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.27%
2024-HK$30.86-35.14%
2023-HK$47.58-56.62%
2022-HK$109.69-19.54%
2021-HK$136.3335.9%
2020-HK$100.32-11.57%
2019-HK$113.4415.24%
2018-HK$98.44-2.78%
2017-HK$101.256.93%
2016-HK$94.69134.88%
2015-HK$40.31-29.51%
2014-HK$57.19-57.34%
2013-HK$134.07146.55%
2012-HK$54.3820.83%
2011-HK$45.00-29.41%
2010-HK$63.75-48.48%
2009-HK$123.7510%
2008-HK$112.5011.11%
2007-HK$101.25-41.3%
2006-HK$172.50-66.91%
2005-HK$521.26110.61%
2004-HK$247.51-61.63%
2003-HK$645.02186.67%
2002-HK$225.01
2001N/A-100%
2000-HK$180.00-63.64%
1999-HK$495.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.50-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$13.44-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$50.94-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.33-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$28.09-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-HK$9.77-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA